Otherwise, obesity-associated endocrine disorders in adipocytes can activate monocytes and subsequently trigger atherosclerosis, and adiponectin can inhibit this process through decreasing TLR4 expression on macrophage/monocytes. Here, ADIPOQ is linked to endocrine system disorder.